Projects

Clinical profile and Outcome of Nephrolithiasis in Children: A Retrospective Study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2022 - 2023

Project Lead

Dr. Arpana Iyengar

Authors

Dr Arpana Iyengar, Dr Shubha A.M, Dr Niveditha Girimaji

Project Status

completed